0
     

Report Added
Report already added
Global Acne Treatment Market 2022-2028

Global Acne Treatment Market 2022-2028

Acne is a skin condition that occurs when your hair follicles become plugged with oil and dead skin cells. It causes whiteheads, blackheads or pimples. Acne is most common among teenagers, though it affects people of all ages. Garnering a CAGR of 5.1% from 2022 to 2028, the global acne treatment market is projected to reach worth of USD 8,690 million by 2028-end, according to a new report by Gen Consulting Company. Increasing sedentary lifestyle and unhealthy food habits, increasing prevalence of acne and facial skin diseases, rise in adoption of skin care products, growing acne cases in geriatric population are expected to boost the market growth in the coming years.Increasing sedentary lifestyle and unhealthy food habits, increasing prevalence of acne and facial skin diseases, rise in adoption of skin care products, growing acne cases in geriatric population are expected to boost the market growth in the coming years.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global acne treatment market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the acne treatment industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the treatment, acne type, end user, and region. The global market for acne treatment can be segmented by treatment: medication, therapeutic devices. The medication segment held the largest share of the global acne treatment market in 2021 and is anticipated to hold its share during the forecast period. Acne treatment market is further segmented by acne type: moderate, mild, moderate to severe. Based on end user, the acne treatment market is segmented into: hospitals & clinics, specialty centers. On the basis of region, the acne treatment market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By treatment:
- medication
- therapeutic devices

By acne type:
- moderate
- mild
- moderate to severe

By end user:
- hospitals & clinics
- specialty centers

By region:
- North America
- Asia Pacific
- Europe
- Rest of the World (ROW)

The medication market is further segmented into retinoids, antibiotics, hormonal agents, others. Furthermore, the medication by drug type market has been categorized into OTC, prescription. The medication by route of administration market is further divided into topical, oral, injectable. The therapeutic devices market is further segmented into laser treatment, microdermabrasion.

The report also provides a detailed analysis of several leading acne treatment market vendors that include Allergan plc, Almirall, S.A., Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Mylan N.V., Perrigo Company plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global acne treatment market.
- To classify and forecast the global acne treatment market based on treatment, acne type, end user, region.
- To identify drivers and challenges for the global acne treatment market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global acne treatment market.
- To identify and analyze the profile of leading players operating in the global acne treatment market.

Why Choose This Report
- Gain a reliable outlook of the global acne treatment market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS

FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY TREATMENT
· Medication
· Therapeutic devices
PART 6. MARKET BREAKDOWN BY ACNE TYPE
· Moderate
· Mild
· Moderate to severe
PART 7. MARKET BREAKDOWN BY END USER
· Hospitals & clinics
· Specialty centers
PART 8. MARKET BREAKDOWN BY REGION
· North America
· Asia Pacific
· Europe
· Rest of the World (ROW)
PART 9. KEY COMPANIES
· Allergan plc
· Almirall, S.A.
· Bausch Health Companies Inc.
· F. Hoffmann-la Roche Ltd.
· Galderma S.A. (Nestle S.A.)
· GlaxoSmithKline Plc (GSK)
· Johnson & Johnson
· Mylan N.V.
· Perrigo Company plc
· Pfizer Inc.
· Teva Pharmaceutical Industries Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Report Title: Global Acne Treatment Market 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM